ALCJCrossject Société Anonyme
1.426EUR-1.38%Mkt Cap: 92.00M $P/E:

Crossject Société Anonyme develops needle-free injection systems in France. The company develops ZENEO, needle-free, pre-filled, single-use auto-injector. It offers Midazolam for epileptic seizure; Terbutaline for the tr…

Key Statistics

Company
Market Cap92.00M $
Enterprise Value101.72M $
Revenue (TTM)2.79M $
Gross Profit-10.56M $
Net Income (TTM)-11.27M $
Revenue/Share0.0533 USD
Last Price1.426 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees99
CountryFR
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN
Valuation
P/E (Trailing)
P/E (Forward)2.78
PEG
EV/EBITDA-8.78
EV/Revenue36.44
P/S33.71
P/B-15.53
EPS (TTM)-0.19
EPS (Forward)0.52
52W Range
1.3466% of range2.695
52W High2.695 EUR
52W Low1.346 EUR
Profitability
Gross Margin0.00%
Oper. Margin-629.28%
EBITDA Margin0.00%
Profit Margin0.00%
ROE212.74%
ROA-34.07%
Growth
Revenue Growth-59.40%
Earnings Growth
Cash Flow & Leverage
Operating CF-6.90M $
CapEx (TTM)4.89M $
FCF Margin-381.37%
FCF Yield-11.57%
Net Debt18.88M $
Net Debt/EBITDA-1.63
Balance Sheet
Debt/Equity-4.61
Current Ratio1.53
Quick Ratio1.12
Book Value/Sh-0.0930 EUR
Cash/Share0.0960 EUR
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 EUR
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)4.400 EUR
Upside (mean)+208.6%
Target Range4.300 EUR4.500 EUR
4.300+208.6% to mean4.500
# Analysts2
Ownership
Shares Out.59.94M
Float51.16M
Insiders19.86%
Institutions0.40%
Technical
SMA 501.653 (-13.7%)
SMA 2001.990 (-28.3%)
Beta0.50
S&P 52W Chg18.16%
Avg Vol (30d)148.10K
Avg Vol (10d)129.85K
Technical Indicators
RSI (14)30.4
MACD-0.0593
MACD Signal-0.0656
MACD Hist.+0.0063
BB Upper1.543 EUR
BB Middle1.486 EUR
BB Lower1.430 EUR
BB Width7.60%
ATR (14)0.0562 EUR
Vol Ratio (20d)1.10x